Artículos por temáticas

Development and validation of a sensitive sandwich ELISA against human PINK1

Baninameh Z, Watzlawik JO, Bustillos BA, Fiorino G, Yan T, Lewicki SL, Zhang H, Dickson DW, Siuda J, Wszolek ZK, Springer W, Fiesel FC.

Autophagy. 2025 May;21(5):1144-1159. doi: 10.1080/15548627.2025.2457915. Epub 2025 Feb 6.

The Role of Machine Learning in Cognitive Impairment in Parkinson Disease: Systematic Review and Meta-Analysis

Wu Y, Cheng Y, Xiao Y, Shang H, Ou R.

J Med Internet Res. 2025 Mar 14;27:e59649. doi: 10.2196/59649.

Unveiling distinct clinical manifestations of primary familial brain calcifications in Asian and European patients: A study based on 10-year individual-level data

Yang D, Huang H, Zeng T, Wang L, Ying C, Chen X, Zhou X, Sun F, Chen Y, Li S, Wang B, Wu S, Xie F, Cen Z, Luo W.

Parkinsonism Relat Disord. 2025 Mar;132:107290. doi: 10.1016/j.parkreldis.2025.107290. Epub 2025 Jan 16.

A case of dementia with Lewy bodies with psychosis induced by low-dose gabapentinoids

Kanemoto H, Akiyama T, Taomoto D, Ikeda M.

BMC Psychiatry. 2025 May 15;25(1):491. doi: 10.1186/s12888-025-06937-7.

Assessing the benefit-risk profile of newer glucose-lowering drugs: A systematic review and network meta-analysis of randomized outcome trials

Tang H, Zhang B, Lu Y, Donahoo WT, Singh Ospina N, Kotecha P, Lu Y, Tong J, Smith SM, Rosenberg EI, Kimmel SE, Bian J, Guo J, Chen Y.

Diabetes Obes Metab. 2025 Mar;27(3):1444-1455. doi: 10.1111/dom.16147. Epub 2024 Dec 26.

Silencer variants are key drivers of gene upregulation in Alzheimer's disease

Huang D, Ovcharenko I.

medRxiv [Preprint]. 2025 Apr 8:2025.04.07.25325386. doi: 10.1101/2025.04.07.25325386.

Eye movement disorders in genetic dystonia syndromes: A literature overview

Pollini L, Pettenuzzo I, Tijssen MAJ, Koens LH, De Koning TJ, Leuzzi V, Eggink H.

Parkinsonism Relat Disord. 2025 Apr;133:107325. doi: 10.1016/j.parkreldis.2025.107325. Epub 2025 Feb 10.

A 29-Year-Old Man With Type 2 Hermansky-Pudlak Syndrome and Wolff-Parkinson-White Syndrome: The Hypothesis of a Potential Link Between These Two Conditions

Alcidi R, Campanella T, Curcio R, Chiatti L, Arrivi A, Ferranti L, Carreras G, Barabani M, Pucci G.

Case Rep Med. 2025 Apr 22;2025:5525411. doi: 10.1155/carm/5525411. eCollection 2025.

Neurodegeneration and the immune system: lessons from autoimmune encephalitis

Campetella L, Smolik K, Farina A, Joubert B, Muñiz-Castrillo S, Desestret V, Honnorat J.

J Neurol. 2025 Apr 24;272(5):359. doi: 10.1007/s00415-025-13094-0.

Flavonoids and their role in oxidative stress, inflammation, and human diseases

Jomova K, Alomar SY, Valko R, Liska J, Nepovimova E, Kuca K, Valko M.

Chem Biol Interact. 2025 May 25;413:111489. doi: 10.1016/j.cbi.2025.111489. Epub 2025 Mar 25.

Relationship of Curcumin with Aging and Alzheimer and Parkinson Disease, the Most Prevalent Age-Related Neurodegenerative Diseases: A Narrative Review

Turer BY, Sanlier N.

Nutr Rev. 2025 Mar 1;83(3):e1243-e1258. doi: 10.1093/nutrit/nuae079.

An Open-Label Pilot Study to Examine the Safety, Tolerability and Efficacy of Deutetrabenazine in Isolated Dystonia

Deik A, Aamodt W, Cadet C, Lasker A, Oliver A, Spindler M, Tropea TF, Vaswani P, Siderowf A.

Mov Disord Clin Pract. 2025 Apr;12(4):504-509. doi: 10.1002/mdc3.14327. Epub 2025 Jan 4.

Environmental Neurotoxins Are Driving the Neurodegeneration Panpidemic

Pizzorno J.

Integr Med (Encinitas). 2025 Apr;24(2):6-9.

The Impact of Cataract Surgery Refusal on Depressive Symptoms and Cognitive Function

Çelik A, Özdoğan S, Erdoğan K.

Psychogeriatrics. 2025 May;25(3):e70048. doi: 10.1111/psyg.70048.

Conformationally adaptive therapeutic peptides for diseases caused by intrinsically disordered proteins (IDPs). New paradigm for drug discovery: Target the target, not the arrow

Fantini J, Azzaz F, Di Scala C, Aulas A, Chahinian H, Yahi N.

Pharmacol Ther. 2025 Mar;267:108797. doi: 10.1016/j.pharmthera.2025.108797. Epub 2025 Jan 17.